Global Bipolar Disorder Market Size, Share, Growth Analysis, By Drug Class(Mood Stabilizers, Anticonvulsants), By Type(Bipolar I Disorder, Bipolar II Disorder)

Description

Global Bipolar Disorder Market was valued at USD 5.3 Billion in 2021, and it is expected to reach a value of USD 6.1 Billion by 2028, at a CAGR of more than 2.12% over the forecast period (2022-2028).

The global bipolar disorder market refers to the market for pharmaceuticals and treatment options used to manage bipolar disorder, which is a mental health condition characterized by episodes of depression and mania. The market for bipolar disorder treatment is driven by several factors, including the increasing prevalence of the disorder, growing awareness and diagnosis of the condition, and the introduction of new and innovative treatment options. The market includes a wide range of products such as mood stabilizers, antipsychotics, antidepressants, and psychotherapy.

Top-down and bottom-up approaches were used to estimate and validate the size of Global Bipolar Disorder Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Segments covered in this report

Global bipolar disorder market is segmented based on the drug class, type, and region. Based on the drug class, the global bipolar disorder market is segmented as mood stabilizers, anticonvulsants, antipsychotic drugs, antidepressant drugs, antianxiety drugs and others. Based on type, the global bipolar disorder market is segmented as, bipolar I disorder, bipolar II disorder, cyclothymic disorder, and others. Based on region, it is categorized into North America, Europe, Asia-Pacific, Latin America, and MEA.

Driver

The global prevalence of bipolar disorder has been increasing in recent years, which is driving the growth of the bipolar disorder market. According to the World Health Organization, bipolar disorder is the sixth leading cause of disability worldwide, affecting an estimated 60 million people globally. The increasing prevalence of bipolar disorder is attributed to factors such as changing lifestyles, increasing stress levels, and genetic factors.

Restraint

Despite significant advances in the diagnosis and treatment of the bipolar disorder, the underlying causes of the condition are not yet fully understood. This can limit the development of effective treatments and make it more challenging to identify patients who are at risk of developing bipolar disorder.

Market Trends

Personalized medicine is an emerging trend in the bipolar disorder market, with a growing focus on developing targeted therapies that address the specific needs of individual patients. Advances in genetics and biomarker research are helping to identify subtypes of bipolar disorder, which could lead to more effective and personalized treatments. Additionally, the development of digital health tools, such as mobile apps and wearables, is enabling the collection of real-time patient data that can be used to inform personalized treatment plans. As the demand for personalized medicine continues to grow, we can expect to see more investment in research and development of targeted therapies for bipolar disorder.

Product Code: SQSG45I2027

Executive Summary

Market overview

Exhibit: Executive Summary - Chart on Market Overview
Exhibit: Executive Summary - Data Table on Market Overview
Exhibit: Executive Summary - Chart on Global Global Bipolar Disorder Market Characteristics
Exhibit: Executive Summary - Chart on Market by Geography
Exhibit: Executive Summary - Chart on Market Segmentation
Exhibit: Executive Summary - Chart on Incremental Growth
Exhibit: Executive Summary - Data Table on Incremental Growth
Exhibit: Executive Summary - Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
Drivers
Opportunities
Restraints
Challenges
SWOT Analysis

KEY MARKET INSIGHTS

Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
Macroeconomic Indicators

COVID IMPACT

Introduction
Impact On Economy-scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
Revised Market Size
- Exhibit: Data Table on Global Global Bipolar Disorder Market size and forecast 2021-2027 ($ million)
Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
Drivers
Opportunities
Restraints
Challenges
Regulatory Landscape
- Exhibit: Data Table on regulation from different region
SWOT Analysis
Porters Analysis
- Competitive rivalry
Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Global Global Bipolar Disorder Market by Drug Class
Market segments
Exhibit: Chart on Market share 2021-2027 (%)
Exhibit: Data table on Market share 2021-2027 (%)
Mood Stabilizers
- Market Estimates & Forecast, 2020-2027
Exhibit: Chart on Market share 2021-2027 (%)
Exhibit: Market size and forecast 2021-2027 ($ million)
Anticonvulsants
- Market Estimates & Forecast, 2020-2027
Exhibit: Chart on Market share 2021-2027 (%)
Exhibit: Market size and forecast 2021-2027 ($ million)
Antipsychotic Drugs
- Market Estimates & Forecast, 2020-2027
Exhibit: Chart on Market share 2021-2027 (%)
Exhibit: Market size and forecast 2021-2027 ($ million)
Antidepressant Drugs
- Market Estimates & Forecast, 2020-2027
Exhibit: Chart on Market share 2021-2027 (%)
Exhibit: Market size and forecast 2021-2027 ($ million)
Antianxiety Drugs
- Market Estimates & Forecast, 2020-2027
Exhibit: Chart on Market share 2021-2027 (%)
Exhibit: Market size and forecast 2021-2027 ($ million)
Other
- Market Estimates & Forecast, 2020-2027
Exhibit: Chart on Market share 2021-2027 (%)
Exhibit: Market size and forecast 2021-2027 ($ million)

Global Global Bipolar Disorder Market by Type

Market segments
Exhibit: Chart on Market share 2021-2027 (%)
Exhibit: Data table on Market share 2021-2027 (%)
Bipolar I Disorder
- Market Estimates & Forecast, 2020-2027
Exhibit: Chart on Market share 2021-2027 (%)
Exhibit: Market size and forecast 2021-2027 ($ million)
Bipolar II Disorder
- Market Estimates & Forecast, 2020-2027
Exhibit: Chart on Market share 2021-2027 (%)
Exhibit: Market size and forecast 2021-2027 ($ million)
Cyclothymic Disorder
- Market Estimates & Forecast, 2020-2027
Exhibit: Chart on Market share 2021-2027 (%)
Exhibit: Market size and forecast 2021-2027 ($ million)
Others
- Market Estimates & Forecast, 2020-2027
Exhibit: Chart on Market share 2021-2027 (%)
Exhibit: Market size and forecast 2021-2027 ($ million)

Market Size by Region

Chart on Market share by geography 2021-2027 (%)
Data Table on Market share by geography 2021-2027(%)
North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
Exhibit: Chart on Market share 2021-2027 (%)
Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
Exhibit: Chart on Market share 2021-2027 (%)
Exhibit: Market size and forecast 2021-2027 ($ million)
Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
Exhibit: Chart on Market share 2021-2027 (%)
Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
Exhibit: Chart on Market share 2021-2027 (%)
Exhibit: Market size and forecast 2021-2027 ($ million)
- France
Exhibit: Chart on Market share 2021-2027 (%)
Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
Exhibit: Chart on Market share 2021-2027 (%)
Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
Exhibit: Chart on Market share 2021-2027 (%)
Exhibit: Market size and forecast 2021-2027 ($ million)
Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
Exhibit: Chart on Market share 2021-2027 (%)
Exhibit: Market size and forecast 2021-2027 ($ million)
- India
Exhibit: Chart on Market share 2021-2027 (%)
Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
Exhibit: Chart on Market share 2021-2027 (%)
Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
Exhibit: Chart on Market share 2021-2027 (%)
Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
Exhibit: Chart on Market share 2021-2027 (%)
Exhibit: Market size and forecast 2021-2027 ($ million)
Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
Exhibit: Chart on Market share 2021-2027 (%)
Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
Exhibit: Chart on Market share 2021-2027 (%)
Exhibit: Market size and forecast 2021-2027 ($ million)
Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
Exhibit: Chart on Market share 2021-2027 (%)
Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
Exhibit: Chart on Market share 2021-2027 (%)
Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
Exhibit: Chart on Market share 2021-2027 (%)
Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

Competitive Landscape
- Total number of companies covered
Exhibit: companies covered in the report, 2021
- Top companies market positioning
Exhibit: company positioning matrix, 2021
- Top companies market Share
Exhibit: Pie chart analysis on company market share, 2021(%)
Allergan (Ireland)AstraZeneca (UK)Eli Lilly and Company (US)GlaxoSmithKline (UK)Abbott (US)Bristol-Myers Squibb (US)Johnson & Johnson (US)Pfizer Inc. (US)Cephalon Inc. (US)Otsuka America Pharmaceutical Inc. (US)Gedeon Richter plc (Hungary)
- Exhibit Company Overview
- Exhibit Business Segment Overview
- Exhibit Financial Updates
- Exhibit Key Developments
Allergan (Ireland)
- Exhibit Company Overview
- Exhibit Business Segment Overview
- Exhibit Financial Updates
- Exhibit Key Developments
AstraZeneca (UK)
- Exhibit Company Overview
- Exhibit Business Segment Overview
- Exhibit Financial Updates
- Exhibit Key Developments
Eli Lilly and Company (US)
- Exhibit Company Overview
- Exhibit Business Segment Overview
- Exhibit Financial Updates
- Exhibit Key Developments
GlaxoSmithKline (UK)
- Exhibit Company Overview
- Exhibit Business Segment Overview
- Exhibit Financial Updates
- Exhibit Key Developments
Abbott (US)
- Exhibit Company Overview
- Exhibit Business Segment Overview
- Exhibit Financial Updates
- Exhibit Key Developments
Bristol-Myers Squibb (US)
- Exhibit Company Overview
- Exhibit Business Segment Overview
- Exhibit Financial Updates
- Exhibit Key Developments
Johnson & Johnson (US)
- Exhibit Company Overview
- Exhibit Business Segment Overview
- Exhibit Financial Updates
- Exhibit Key Developments
Pfizer Inc. (US)
- Exhibit Company Overview
- Exhibit Business Segment Overview
- Exhibit Financial Updates
- Exhibit Key Developments
Cephalon Inc. (US)
- Exhibit Company Overview
- Exhibit Business Segment Overview
- Exhibit Financial Updates
- Exhibit Key Developments
Otsuka America Pharmaceutical Inc. (US)
- Exhibit Company Overview
- Exhibit Business Segment Overview
- Exhibit Financial Updates
- Exhibit Key Developments
Gedeon Richter plc (Hungary)
- Exhibit Company Overview
- Exhibit Business Segment Overview
- Exhibit Financial Updates
- Exhibit Key Developments

Global Bipolar Disorder Market Size, Share, Growth Analysis, By Drug Class(Mood Stabilizers, Anticonvulsants), By Type(Bipolar I Disorder, Bipolar II Disorder) - Industry Forecast 2022-2028

Description

Table of Contents

Table of Contents

Executive Summary

Market overview

Parent Market Analysis

Market overview

Market size

KEY MARKET INSIGHTS

COVID IMPACT

MARKET DYNAMICS & OUTLOOK

Global Global Bipolar Disorder Market by Type

Market Size by Region

KEY COMPANY PROFILES